P. van Brummelen

4.8k total citations
136 papers, 3.9k citations indexed

About

P. van Brummelen is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, P. van Brummelen has authored 136 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Cardiology and Cardiovascular Medicine, 29 papers in Molecular Biology and 23 papers in Surgery. Recurrent topics in P. van Brummelen's work include Blood Pressure and Hypertension Studies (23 papers), Receptor Mechanisms and Signaling (19 papers) and Heart Rate Variability and Autonomic Control (17 papers). P. van Brummelen is often cited by papers focused on Blood Pressure and Hypertension Studies (23 papers), Receptor Mechanisms and Signaling (19 papers) and Heart Rate Variability and Autonomic Control (17 papers). P. van Brummelen collaborates with scholars based in Netherlands, Switzerland and China. P. van Brummelen's co-authors include C. H. Kleinbloesem, D. D. Breimer, Meindert Danhof, J. Van Harten, D.D. Breimer, Fritz R. Bühler, Maarten A.D.H. Schalekamp, Wolfgang Kiowski, M. I. Koolen and Hette Faber and has published in prestigious journals such as The Lancet, Circulation and Circulation Research.

In The Last Decade

P. van Brummelen

135 papers receiving 3.6k citations

Peers

Countries citing papers authored by P. van Brummelen

Since Specialization

Citations

This map shows the geographic impact of P. van Brummelen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. van Brummelen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. van Brummelen more than expected).

Fields of papers citing papers by P. van Brummelen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. van Brummelen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. van Brummelen. The network helps show where P. van Brummelen may publish in the future.

Co-authorship network of co-authors of P. van Brummelen

This figure shows the co-authorship network connecting the top 25 collaborators of P. van Brummelen. A scholar is included among the top collaborators of P. van Brummelen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. van Brummelen. P. van Brummelen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Integrated pharmacokinetics and pharmacodynamics of the novel catechol-O-methyltransferase inhibitor tolcapone during first administration to humans* 1995 ·Clinical Pharmacology & Therapeutics ·Jasper Dingemanse, Karin Jorga, Monique Schmitt, Ronald Gieschke, (unknown), G. Zürcher, M. Da Prada, P. van Brummelen	96
2	Comparison of blood pressure and angiotensin responses to the renin inhibitor Ro 42-5892 and the angiotensin converting enzyme inhibitor enalapril in essential hypertension 1993 ·Journal of Hypertension ·Anton H. van den Meiracker, Peter J.J. Admiraal, F. H. M. Derkx, (unknown), (unknown), P. van Brummelen, Paul Mulder, Maarten A.D.H. Schalekamp	20
3	Functional and structural determinants of glomerulosclerosis in the fawn‐hooded rat 1992 ·European Journal of Clinical Investigation ·Pieter J. Westenend, (unknown), (unknown), P. van Brummelen, Jan J. Weening	11
4	Serotonergic Receptors and Drugs in Hypertension 1992 ·Pharmacology & Toxicology ·P. A. van Zwieten, Gerard J. Blauw, P. van Brummelen	28
5	Clinical Pharmacology of Cilazapril 1991 ·Drugs ·(unknown), P. van Brummelen, Robert J. Francis, (unknown)	9
6	Effect of the Renin Response During Renin Inhibition 1991 ·Journal of Cardiovascular Pharmacology ·Edoardo Camenzind, Jürg Nussberger, Lucienne Juillerat, Alain Munafo, Walter Fischli, Philippe Coassolo, P. van Brummelen, (unknown), Bernard Waeber, Hans R. Brunner	28
7	The acute and chronic antihypertensive effects of ketanserin cannot be explained by blockade of vascular serotonin, type 2, receptors Or α1-adrenergic receptors 1991 ·Clinical Pharmacology & Therapeutics ·Gerard J. Blauw, P. van Brummelen, (unknown), E. A. van der Velde, Pieter A. van Zwieten	11
8	Prolonged blood pressure reduction by orally active renin inhibitor RO 42-5892 in essential hypertension. 1990 ·BMJ ·Anton H. van den Meiracker, P J Admiraal, (unknown), F. H. M. Derkx, Henk J. Ritsema van Eck, Paul Mulder, P. van Brummelen, Maarten A.D.H. Schalekamp	46
9	Pharmacological Profile of Antihypertensive Drugs with Serotonin Receptor and α-Adrenoceptor Activity 1990 ·Drugs ·P. A. van Zwieten, Gerard J. Blauw, P. van Brummelen	19
10	Arterial and Venous Effects of Serotonin in the Forearm of Healthy Subjects Are Not Age-Related 1989 ·Journal of Cardiovascular Pharmacology ·Gerard J. Blauw, P. van Brummelen, Peter C. Chang, Pieter Vermeij, Pieter A. van Zwieten	15
11	Influence of Renal Function on the Pharmacokinetics and Cardiovascular Effects of Nisoldipine After Single and Multiple Dosing 1989 ·Clinical Pharmacokinetics ·J. Van Harten, J. Burggraaf, P. van Brummelen, D. D. Breimer	13
12	Variability in the Pharmacokinetics of Nisoldipine as Caused by Differences in Liver Blood Flow Response 1989 ·The Journal of Clinical Pharmacology ·J. Van Harten, P. van Brummelen, (unknown), Meindert Danhof, Gerard J. Blauw, D.D. Breimer	9
13	The influence of infusion rate on the pharmacokinetics and haemodynamic effects of nisoldipine in man. 1988 ·British Journal of Clinical Pharmacology ·J. Van Harten, P. van Brummelen, (unknown), Meindert Danhof, (unknown)	21
14	5HT3 receptor-mediated vasodilation in the human forearm 1988 ·Journal of Hypertension ·Gerard J. Blauw, P. van Brummelen, Peter C. Chang, Pieter Vermeij, Pieter A. van Zwieten	14
15	A microcomputer-based, R-wave triggered system for hemodynamic measurements in the forearm 1988 ·Computers in Biology and Medicine ·Peter C. Chang, (unknown), Tobias A. Bruning, P. van Brummelen	36
16	Local Hemodynamic Effects of Serotonin and Ketanserin in Healthy Subjects 1988 ·Journal of Cardiovascular Pharmacology ·Gerard J. Blauw, P. van Brummelen, Tobias A. Bruning, Pieter A. van Zwieten	2
17	NEGLIGIBLE SUBLINGUAL ABSORPTION OF NIFEDIPINE 1987 ·The Lancet ·J. Van Harten, Meindert Danhof, (unknown), P. van Brummelen, (unknown)	75
18	Gas chromatographic determination of nisoldipine and one of its metabolites in plasma 1987 ·Journal of Chromatography B Biomedical Sciences and Applications ·J. Van Harten, (unknown), (unknown), P. van Brummelen, D. D. Breimer	33
19	α-Adrenergic receptors in human blood vessels 1986 ·British Journal of Clinical Pharmacology ·P. van Brummelen, (unknown), P. A. van Zwieten	12
20	The Role of Anger in Hypertension 1985 ·Psychotherapy and Psychosomatics ·Henk M. van der Ploeg, (unknown), P. van Brummelen	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact